Ernexa Therapeutics, Inc. (ERNA)
4.30
+0.14
(+3.24%)
USD |
NASDAQ |
Sep 14, 10:34
Ernexa Therapeutics Total Assets (Quarterly) : 6.315M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.315M |
| March 31, 2026 | 10.54M |
| December 31, 2025 | 5.834M |
| September 30, 2025 | 6.172M |
| June 30, 2025 | 7.584M |
| March 31, 2025 | 5.059M |
| December 31, 2024 | 5.269M |
| September 30, 2024 | 7.718M |
| June 30, 2024 | 46.49M |
| March 31, 2024 | 49.66M |
| December 31, 2023 | 49.13M |
| September 30, 2023 | 52.25M |
| June 30, 2023 | 46.95M |
| March 31, 2023 | 15.11M |
| December 31, 2022 | 22.28M |
| September 30, 2022 | 20.93M |
| June 30, 2022 | 26.90M |
| March 31, 2022 | 35.38M |
| December 31, 2021 | 31.52M |
| September 30, 2021 | 39.39M |
| June 30, 2021 | 64.71M |
| March 31, 2021 | 20.70M |
| December 31, 2020 | 13.78M |
| September 30, 2020 | 5.054M |
| June 30, 2020 | 6.79M |
| Date | Value |
|---|---|
| March 31, 2020 | 11.01M |
| December 31, 2019 | 15.28M |
| September 30, 2019 | 14.92M |
| June 30, 2019 | 15.64M |
| March 31, 2019 | 16.48M |
| December 31, 2018 | 14.86M |
| September 30, 2018 | 15.54M |
| June 30, 2018 | 16.36M |
| March 31, 2018 | 15.70M |
| December 31, 2017 | 16.57M |
| September 30, 2017 | 17.56M |
| June 30, 2017 | 18.53M |
| March 31, 2017 | 17.53M |
| December 31, 2016 | 17.14M |
| September 30, 2016 | 14.40M |
| June 30, 2016 | 14.96M |
| March 31, 2016 | 16.32M |
| December 31, 2015 | 16.82M |
| September 30, 2015 | 17.28M |
| June 30, 2015 | 17.24M |
| March 31, 2015 | 20.16M |
| December 31, 2014 | 22.95M |
| September 30, 2014 | 22.56M |
| June 30, 2014 | 22.58M |
| March 31, 2014 | 15.52M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cerenome, Inc. | 14.03M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.115M |
| Shareholders Equity (Quarterly) | 3.20M |
| Debt to Equity Ratio | 0.1091 |
| Current Ratio | 2.010 |
| Net Debt Paydown Yield | 6.51% |